EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Pemigatinib therapy in myeloid/lymphoid neoplasm with FGFR1 rearrangement manifesting as aggressive B-cell lymphoma

Kenichi Ito, Kazuhiko Hirano, Naohiro Sekiguchi

Journal of Clinical and Experimental Hematopathology · 2025

DOI: 10.3960/jslrt.25027 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2025. Verfasst von Kenichi Ito und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Division, National Hospital Organization Disaster Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Pyrimidines, Gene Rearrangement, Lymphoma, B-Cell. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 1PyrimidinesGene RearrangementLymphoma, B-CellMorpholinesPyrrolesHumansFemaleAged

Stichwörter der Autor:innen

8p11.2FGFR1myeloid/lymphoid neoplasm with FGFR1 rearrangementpemigatinib

Substanzen

Receptor, Fibroblast Growth Factor, Type 1PyrimidinesFGFR1 protein, humanpemigatinibMorpholinesPyrroles

Autor:innen und Institutionen

  • Hematology Division, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
  • Laboratory and Pathology Division, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
  • Clinical Research Division, National Hospital Organization Disaster Medical Center, Tokyo, Japan.

Zitieren

APA

Ito, K., Hirano, K., & Sekiguchi, N. (2025). Pemigatinib therapy in myeloid/lymphoid neoplasm with FGFR1 rearrangement manifesting as aggressive B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.25027

Vancouver

Ito K, Hirano K, Sekiguchi N. Pemigatinib therapy in myeloid/lymphoid neoplasm with FGFR1 rearrangement manifesting as aggressive B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. 2025. doi:10.3960/jslrt.25027

BibTeX
@article{Ito2025,
  author = {Ito, Kenichi and Hirano, Kazuhiko and Sekiguchi, Naohiro},
  title = {Pemigatinib therapy in myeloid/lymphoid neoplasm with FGFR1 rearrangement manifesting as aggressive B-cell lymphoma},
  journal = {Journal of Clinical and Experimental Hematopathology},
  year = {2025},
  doi = {10.3960/jslrt.25027}
}
Kostenlos starten →